These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2459191)

  • 21. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligosaccharide-dependent and independent Qa-1 determinants.
    Jenkins RN; Aldrich CJ; Lopez LA; Rich RR
    J Immunol; 1985 May; 134(5):3218-25. PubMed ID: 2580018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of phosphatidylinositol-dependent phospholipase C sensitive Qa-2 antigen is increased on peripheral blood lymphocytes of aging mice.
    Armstrong MJ; Warner CM
    Growth Dev Aging; 1992; 56(4):225-36. PubMed ID: 1487361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qa-1/Tla region alloantigen-specific CTL with alpha beta receptor.
    Germana S; Shinohara N
    Immunology; 1991 Dec; 74(4):578-82. PubMed ID: 1838350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions.
    Spits H; Paliard X; De Vries JE
    J Immunol; 1989 Sep; 143(5):1506-11. PubMed ID: 2474601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.
    Nell LJ; Cook RG; Rich RR
    Transplantation; 1982 Jul; 34(1):54-9. PubMed ID: 6181592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
    Pala P; Corradin G; Strachan T; Sodoyer R; Jordan BR; Cerottini JC; Maryanski JL
    J Immunol; 1988 Feb; 140(3):871-7. PubMed ID: 2448379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL; Guimezanes A; Schmitt-Verhulst AM
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of phosphatidylinositol-anchored proteins in T cell activation.
    Presky DH; Low MG; Shevach EM
    J Immunol; 1990 Feb; 144(3):860-8. PubMed ID: 1967276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
    Bevan MJ; Langman RE; Cohn M
    Eur J Immunol; 1976 Mar; 6(3):150-6. PubMed ID: 62665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of T cell receptors specific for recognition of class IB antigens.
    Lowen LC; Aldrich CJ; Forman J
    J Immunol; 1993 Dec; 151(11):6155-65. PubMed ID: 8245458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region.
    Forman J
    J Immunol; 1979 Dec; 123(6):2451-5. PubMed ID: 387870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R; Böhm W; Reimann J
    J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens.
    Cassell DJ; Forman J
    J Immunol; 1990 Jun; 144(11):4075-81. PubMed ID: 2140385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.